Accessibility Help | Sitemap | Contact Us | Customer Support CALL 1-800-275-4524
United States Change Country
Careers | Investor Relations | News & Media | Events | KCI Recycling | About KCI
Home  |  Conditions  |  Products  |  Clinical Evidence  |  Education and Training  |  For Patients  |  Customer Support  |  Suppliers
You are here: Home > About KCI > News & Media > Media Information > KCI V.A.C.® GranuFoam™ Bridge XG Dressing Aids in the Treatment of Pressure Ulcers

KCI V.A.C.® GranuFoam™ Bridge XG Dressing Aids in the Treatment of Pressure Ulcers

Released : January 17th 2011

Pressure Ulcers that can benefit from NPWT represent $1 Billion Market Opportunity in the U.S.

KCI, Leader in Advanced Wound Care Solutions

SAN ANTONIO—(BUSINESS WIRE)— Kinetic Concepts, Inc. (NYSE:KCI) announced today that it has commercially launched its new V.A.C.® GranuFoam Bridge XG Dressing. The V.A.C.® GranuFoam Bridge XG Dressing enables more complete coverage of large wounds requiring bridging, including difficult to access pressure ulcers.

Intended for use with KCI Vacuum Assisted Closure (V.A.C.)® Therapy Units, the V.A.C.® GranuFoam Bridge XG Dressing offers the traditional healing benefits of the V.A.C.® GranuFoam Dressing, while allowing for bridging of the SensaT.R.A.C. Pad away from the wound site and simplified dressing application. Retrospective studies have shown V.A.C.® Therapy can have a positive impact on the treatment of pressure ulcers.1,2 Also, V.A.C.® Therapy Systems with SensaT.R.A.C. technology are the only NPWT devices that monitor and adjust negative pressure delivery at the wound site.

An estimated 2.5 million patients are treated annually for pressure ulcers in U.S. acute care facilities alone. The treatment of this condition has become a costly challenge for clinicians and healthcare providers, with the cost to care for an advanced (stage III and IV) pressure ulcer estimated as high as $70,000 per case. The total annual healthcare costs for the treatment of pressure ulcers are estimated to be more than $11 billion per year.3

"Pressure ulcers can be debilitating and painful, and we designed the V.A.C.® GranuFoam Bridge XG Dressing with patient treatment and comfort in mind," said Mike Genau, global president of KCI's Active Healing Solutions business. "Combined with the clinically proven effectiveness of V.A.C.® Therapy, our new dressing may help provide improved quality of life for Stage III and IV pressure ulcer patients during the wound treatment and healing process."

The V.A.C.® GranuFoam Bridge XG Dressing combines the extended reach of the V.A.C.® GranuFoam Bridge Dressing with the ease of use from the spiral-shaped GranuFoam Dressing for wound placement introduced with the V.A.C.® Simplace Dressings.

"The V.A.C.® GranuFoam Bridge XG has helped increase my case efficiency significantly by allowing for easier patient treatment, a reduction in dressing application time and, consequently, a positive impact on total treatment costs," said Dr. Adam Ravin, MD, Plastic Surgeon at NorthEast Plastic and Reconstructive Surgery in Concord, N.C. "I believe V.A.C. ® Therapy's clinical approach, with the addition of the V.A.C.® GranuFoam Bridge XG to the treatment of large wounds requiring bridging, provides effective results for patient care."

The V.A.C. ® GranuFoam Bridge XG Dressing is now commercially available in the United States.

About KCI

Kinetic Concepts, Inc. (NYSE:KCI) is a leading global medical technology company devoted to the discovery, development, manufacture and marketing of innovative, high-technology therapies and products for the wound care, tissue regeneration and therapeutic support system markets. Headquartered in San Antonio, Texas, KCI's success spans more than three decades and can be traced to a history deeply rooted in innovation and a passion for significantly improving the healing and the lives of patients around the world.

The company employs approximately 6,800 people and markets its products in 20 countries. For more information about KCI, and how its products are changing the practice of medicine, visit

All trademarks designated herein are proprietary to KCI Licensing, Inc. its affiliates and/or licensors.

  1. Schwien T, Gilbert J, Lang C. Pressure ulcer prevalence and the role of negative pressure wound therapy in home health quality outcomes. Ostomy/Wound Management. 2005 Sep;51(9):47-60.
  2. Baharestani MM, Houliston-Otto DB, Barnes S. Early versus late initiation of negative pressure wound therapy: examining the impact on home care length of stay. Ostomy Wound Management. 2008 Nov;54(11):48-53.
  3. Baharestani M, de Leon J, Mendez-Eastman S, et al. Consensus Statement: A Practical Guide for Managing Pressure Ulcers with Negative Pressure Wound Therapy Utilizing Vacuum-Assisted Closure.- Understanding the Treatment Algorithm. Advances in Skin and Wound Care. 2008 Jan;21(Suppl1):1-20.


Kinetic Concepts, Inc.
Media Relations: for journalists only.
Investors Relations: for Investor Relations inquiries.

  • KCI Express
  • Share on
  • Share on Twitter
  • Visit our YouTube page

Important Message for Patients

Terms of Use | Privacy Notice | Safe Harbor Policy | Contact Us | News Feed

Copyright © 1998 - 2013 KCI Licensing, Inc. All Rights Reserved.    DSL# 09-03-193
The information included in this Web site has been prepared for and is intended for viewing exclusively within the United States of America. This Web site contains information about products which may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please consult individual country sites for approved uses and any applicable restrictions.